25 September 2020Additional information relating to breastfeeding To be used in conjunction with individual drug entries for specific information and guidance. There is no evidence for the…
Medicine Compliance Aid Stability
Tablets f/c 625mg
A3 · Amber 3 No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from moisture
Protect from moisture.
9 November 2015
Lactation Safety Information
No published evidence of safety
Not absorbed from the mother’s GI tract
Theoretical effects of colestryramine on maternal cholesterol levels and availability of fat soluble vitamins (A, D, E, K) from the mother have not been shown to present a clinical risk to a breastfed infant
18 March 2017